High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies.
acute leukaemia
allogeneic hematopoietic stem cell transplantation
antifungal prophylaxis
invasive fungal diseases
neutropenic fever
Journal
Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893
Informations de publication
Date de publication:
06 Jan 2024
06 Jan 2024
Historique:
received:
11
12
2023
revised:
30
12
2023
accepted:
03
01
2024
medline:
23
1
2024
pubmed:
23
1
2024
entrez:
23
1
2024
Statut:
epublish
Résumé
Invasive fungal diseases (IFDs) still represent a relevant cause of mortality in patients affected by hematological malignancies, especially acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS) undergoing remission induction chemotherapy, and in allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. Mold-active antifungal prophylaxis (MAP) has been established as a standard of care. However, breakthrough IFDs (b-IFDs) have emerged as a significant issue, particularly invasive aspergillosis and non-
Identifiants
pubmed: 38257945
pii: microorganisms12010117
doi: 10.3390/microorganisms12010117
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng